Sanofi ADR (SNY)

52.39
-0.51(-0.96%)
Pre Market
52.82
+0.43(+0.82%)
- Real-time Data
  • Volume:
    1,011,129
  • Day's Range:
    52.38 - 53.41
  • 52 wk Range:
    46.92 - 58.10

SNY Overview

Prev. Close
52.9
Day's Range
52.38-53.41
Revenue
68.29B
Open
53.41
52 wk Range
46.92-58.1
EPS
2.77
Volume
1,011,129
Market Cap
131.05B
Dividend (Yield)
1.2976
(2.48%)
Average Volume (3m)
2,200,198
P/E Ratio
18.89
Beta
0.47
1-Year Change
-2.02%
Shares Outstanding
1,248,657,151
Next Earnings Date
27 Jul 2022
What is your sentiment on Sanofi ADR?
or
Market is currently closed. Voting is open during market hours.

Sanofi ADR News

Sanofi ADR Analysis

Sanofi ADR Company Profile

Sanofi ADR Company Profile

Employees
95442

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellBuyStrong Buy
Technical IndicatorsStrong SellStrong SellStrong SellNeutralStrong Buy
SummaryStrong SellStrong SellStrong SellNeutralStrong Buy